semaglutide patent expiry europe Ozempic just got much, much cheaper in India. On March 21, Danish company Novo Nordisk's on semaglutide, the active ingredient behind its diabetes and weight-loss drugs Ozempic and Wegovy, expired in Aspen Pharmacare wins Canada approval

Use code: STARTGLP1

There are ways to save on Wegovy if you do not have insurance coverage: Use a SingleCare prescription discount card to save over $700 per month on Wegovy or Wegovy HD

Patients taking insulin or other diabetes medications should discuss timing strategies with their healthcare provider to optimize overall diabetes management and minimize hypoglycemia risk, though semaglutide itself has low hypoglycemia risk when used without insulin or sulfonylureas

Thirst may indicate hyperglycaemia requiring blood glucose monitoring and possible treatment adjustment

Clinical characteristics and disease outcomes in non-diabetic chronic kidney disease: retrospective analysis of a US healthcare claims database

Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes - 2026